{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "METRN\u03b2", "biomarker", "cytokines", "prognostic"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36798115", "DateCompleted": {"Year": "2023", "Month": "02", "Day": "22"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "01", "Day": "31"}], "Language": ["eng"], "ELocationID": ["1111920", "10.3389/fimmu.2023.1111920"], "Journal": {"ISSN": "1664-3224", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2023"}}, "Title": "Frontiers in immunology", "ISOAbbreviation": "Front Immunol"}, "ArticleTitle": "Characterization of METRN\u03b2 as a novel biomarker of Coronavirus disease 2019 severity and prognosis.", "Pagination": {"StartPage": "1111920", "MedlinePgn": "1111920"}, "Abstract": {"AbstractText": ["Coronavirus disease 2019 (COVID-19) is increasing worldwide, with complications due to frequent viral mutations, an intricate pathophysiology, and variable host immune responses. Biomarkers with predictive and prognostic value are crucial but lacking.", "Serum samples from authentic and D614G variant (non-Omicron), and Omicron-SARS-CoV-2 infected patients were collected for METRN\u03b2 detection and longitudinal cytokine/chemokine analysis. Correlation analyses were performed to compare the relationships between serum METRN\u03b2 levels and cytokines/chemokines, laboratory parameters, and disease severity. Receiver operating characteristic (ROC) curves and Kaplan-Meier survival curves were used to evaluate the predictive value of METRN\u03b2 in COVID-19.", "The serum level of METRN\u03b2 was highly elevated in non-Omicron-SARS-CoV-2 infected patients compared to healthy individuals, and the non-survivor displayed higher METRN\u03b2 levels than survivors among the critical ones. METRN\u03b2 concentration showed positive correlation with viral load in NAPS. ROC curve showed that a baseline METRN\u03b2 level of 1886.89 pg/ml distinguished COVID-19 patients from non-infected individuals with an AUC of 0.830. Longitudinal analysis of cytokine/chemokine profiles revealed a positive correlation between METRN\u03b2 and pro-inflammatory cytokines such as IL6, and an inverse correlation with soluble CD40L (sCD40L). Higher METRN\u03b2 was associated with increased mortality. These findings were validated in a second and third cohort of COVID-19 patients identified in a subsequent wave.", "Our study uncovered the precise role of METRN\u03b2 in predicting the severity of COVID-19, thus providing a scientific basis for further evaluation of the role of METRN\u03b2 in triage therapeutic strategies."], "CopyrightInformation": "Copyright \u00a9 2023 Gao, Chan, Wong, Ng, Yeung, Lui, Ling, Hui, Huang and Wong."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing, China."}, {"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}], "LastName": "Gao", "ForeName": "Xun", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}, {"Identifier": [], "Affiliation": "Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}], "LastName": "Chan", "ForeName": "Paul Kay-Sheung", "Initials": "PK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}], "LastName": "Wong", "ForeName": "Katie Ching-Yau", "Initials": "KC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}], "LastName": "Ng", "ForeName": "Rita Wai-Yin", "Initials": "RW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}], "LastName": "Yeung", "ForeName": "Apple Chung-Man", "Initials": "AC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}, {"Identifier": [], "Affiliation": "Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}], "LastName": "Lui", "ForeName": "Grace Chung-Yan", "Initials": "GC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}], "LastName": "Ling", "ForeName": "Lowell", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}, {"Identifier": [], "Affiliation": "Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}], "LastName": "Hui", "ForeName": "David Shu-Cheong", "Initials": "DS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}], "LastName": "Huang", "ForeName": "Danqi", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}, {"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}, {"Identifier": [], "Affiliation": "Li Dak Sum Yip Yio Chin R & D Centre for Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China."}], "LastName": "Wong", "ForeName": "Chun-Kwok", "Initials": "CK"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Immunol", "NlmUniqueID": "101560960", "ISSNLinking": "1664-3224"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Chemokines"}], "SupplMeshList": ["SARS-CoV-2 variants"], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Prognosis"}, {"QualifierName": [], "DescriptorName": "Biomarkers"}, {"QualifierName": [], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Chemokines"}], "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. . Clinical characteristics of coronavirus disease 2019 in china. N Engl J Med (2020) 382:1708\u201320. doi: 10.1056/NEJMoa2002032", "ArticleIdList": ["10.1056/NEJMoa2002032", "PMC7092819", "32109013"]}, {"Citation": "Huang D, Lian X, Song F, Ma H, Lian Z, Liang Y, et al. . Clinical features of severe patients infected with 2019 novel coronavirus: A systematic review and meta-analysis. Ann Transl Med (2020) 8:576. doi: 10.21037/atm-20-2124", "ArticleIdList": ["10.21037/atm-20-2124", "PMC7290556", "32566603"]}, {"Citation": "Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in wuhan, china. Lancet. (2020) 395:497\u2013506. doi: 10.1016/S0140-6736(20)30183-5", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, et al. . Induction of pro-inflammatory cytokines (il-1 and il-6) and lung inflammation by coronavirus-19 (covi-19 or sars-cov-2): Anti-inflammatory strategies. J Biol Regul Homeost Agents. (2020) 34:327\u201331. doi: 10.23812/20-1-E", "ArticleIdList": ["10.23812/20-1-E", "32171193"]}, {"Citation": "Merad M, Martin JC. Pathological inflammation in patients with covid-19: A key role for monocytes and macrophages. Nat Rev Immunol (2020) 20:355\u201362. doi: 10.1038/s41577-020-0331-4", "ArticleIdList": ["10.1038/s41577-020-0331-4", "PMC7201395", "32376901"]}, {"Citation": "Zhang X, Tan Y, Ling Y, Lu G, Liu F, Yi Z, et al. . Viral and host factors related to the clinical outcome of covid-19. Nature. (2020) 583:437\u201340. doi: 10.1038/s41586-020-2355-0", "ArticleIdList": ["10.1038/s41586-020-2355-0", "32434211"]}, {"Citation": "Ling L, Chen Z, Lui G, Wong CK, Wong WT, Ng RWY, et al. . Longitudinal cytokine profile in patients with mild to critical covid-19. Front Immunol (2021) 12:763292. doi: 10.3389/fimmu.2021.763292", "ArticleIdList": ["10.3389/fimmu.2021.763292", "PMC8685399", "34938289"]}, {"Citation": "Xu X, Han M, Li T, Sun W, Wang D, Fu B, et al. . Effective treatment of severe covid-19 patients with tocilizumab. Proc Natl Acad Sci U S A. (2020) 117:10970\u20135. doi: 10.1073/pnas.2005615117", "ArticleIdList": ["10.1073/pnas.2005615117", "PMC7245089", "32350134"]}, {"Citation": "Gao X, Chan PKS, Lui GCY, Hui DSC, Chu IM, Sun X, et al. . Interleukin-38 ameliorates poly(i:C) induced lung inflammation: Therapeutic implications in respiratory viral infections. Cell Death Dis (2021) 12:53. doi: 10.1038/s41419-020-03283-2", "ArticleIdList": ["10.1038/s41419-020-03283-2", "PMC7790341", "33414457"]}, {"Citation": "Gao X, Wu G, Tsang MS, Huang D, Lam CW, Wong CK. Novel insights into the role of anti-inflammatory il-38 in immunity against infection. Cell Mol Immunol (2022) 19:1322\u20134. doi: 10.1038/s41423-022-00876-z", "ArticleIdList": ["10.1038/s41423-022-00876-z", "PMC9379218", "35974108"]}, {"Citation": "Zhang JJY, Lee KS, Ang LW, Leo YS, Young BE. Risk factors for severe disease and efficacy of treatment in patients infected with covid-19: A systematic review, meta-analysis, and meta-regression analysis. Clin Infect Dis (2020) 71:2199\u2013206. doi: 10.1093/cid/ciaa576", "ArticleIdList": ["10.1093/cid/ciaa576", "PMC7239203", "32407459"]}, {"Citation": "Wang G, Wu C, Zhang Q, Wu F, Yu B, Lv J, et al. . C-reactive protein level may predict the risk of covid-19 aggravation. Open Forum Infect Dis (2020) 7:ofaa153. doi: 10.1093/ofid/ofaa153", "ArticleIdList": ["10.1093/ofid/ofaa153", "PMC7197542", "32455147"]}, {"Citation": "Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, et al. . Covid-19 and coagulation: Bleeding and thrombotic manifestations of sars-cov-2 infection. Blood. (2020) 136:489\u2013500. doi: 10.1182/blood.2020006520", "ArticleIdList": ["10.1182/blood.2020006520", "PMC7378457", "32492712"]}, {"Citation": "Baht GS, Bareja A, Lee DE, Rao RR, Huang R, Huebner JL, et al. . Meteorin-like facilitates skeletal muscle repair through a stat3/igf-1 mechanism. Nat Metab (2020) 2:278\u201389. doi: 10.1038/s42255-020-0184-y", "ArticleIdList": ["10.1038/s42255-020-0184-y", "PMC7504545", "32694780"]}, {"Citation": "Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I, et al. . Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell. (2014) 157:1279\u201391. doi: 10.1016/j.cell.2014.03.065", "ArticleIdList": ["10.1016/j.cell.2014.03.065", "PMC4131287", "24906147"]}, {"Citation": "Ushach I, Burkhardt AM, Martinez C, Hevezi PA, Gerber PA, Buhren BA, et al. . Meteorin-like is a cytokine associated with barrier tissues and alternatively activated macrophages. Clin Immunol (2015) 156:119\u201327. doi: 10.1016/j.clim.2014.11.006", "ArticleIdList": ["10.1016/j.clim.2014.11.006", "PMC4336607", "25486603"]}, {"Citation": "Ushach I, Arrevillaga-Boni G, Heller GN, Pone E, Hernandez-Ruiz M, Catalan-Dibene J, et al. . Meteorin-like/meteorin-\u03b2 is a novel immunoregulatory cytokine associated with inflammation. J Immunol (2018) 201:3669\u201376. doi: 10.4049/jimmunol.1800435", "ArticleIdList": ["10.4049/jimmunol.1800435", "PMC6394858", "30464051"]}, {"Citation": "Rup\u00e9rez C, Ferrer-Curriu G, Cervera-Barea A, Florit L, Guitart-Mampel M, Garrabou G, et al. . Meteorin-like/meteorin-\u03b2 protects heart against cardiac dysfunction. J Exp Med (2021) 218:e20201206. doi: 10.1084/jem.20201206", "ArticleIdList": ["10.1084/jem.20201206", "PMC7923691", "33635944"]}, {"Citation": "Miao ZW, Hu WJ, Li ZY, Miao CY. Involvement of the secreted protein metrnl in human diseases. Acta Pharmacol Sin (2020) 41:1525\u201330. doi: 10.1038/s41401-020-00529-9", "ArticleIdList": ["10.1038/s41401-020-00529-9", "PMC7921639", "32999412"]}, {"Citation": "Gao X, Leung TF, Wong GW, Ko WH, Cai M, He EJ, et al. . Meteorin-\u03b2/meteorin like/il-41 attenuates airway inflammation in house dust mite-induced allergic asthma. Cell Mol Immunol (2022) 19:245\u201359. doi: 10.1038/s41423-021-00803-8", "ArticleIdList": ["10.1038/s41423-021-00803-8", "PMC8803866", "34848868"]}, {"Citation": "Prevention UCfDCa. 2019-novel coronavirus (2019-ncov) real-time rrt-pcr panel primers and probes (Accessed 28 Jan 2020)."}, {"Citation": "Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, et al. . An inflammatory cytokine signature predicts covid-19 severity and survival. Nat Med (2020) 26:1636\u201343. doi: 10.1038/s41591-020-1051-9", "ArticleIdList": ["10.1038/s41591-020-1051-9", "PMC7869028", "32839624"]}, {"Citation": "Faqihi F, Alharthy A, Memish ZA, Karakitsos D. Comment on hu et\u00a0al: The cytokine storm and covid-19. J Med Virol (2021) 93:631\u20133. doi: 10.1002/jmv.26396", "ArticleIdList": ["10.1002/jmv.26396", "PMC7436490", "32761905"]}, {"Citation": "de Bruin S, Bos LD, van Roon MA, Tuip-de Boer AM, Schuurman AR, Koel-Simmelinck MJA, et al. . Clinical features and prognostic factors in covid-19: A prospective cohort study. EBioMedicine. (2021) 67:103378. doi: 10.1016/j.ebiom.2021.103378", "ArticleIdList": ["10.1016/j.ebiom.2021.103378", "PMC8118723", "34000622"]}, {"Citation": "Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, et al. . Prognostic value of interleukin-6, c-reactive protein, and procalcitonin in patients with covid-19. J Clin Virol (2020) 127:104370. doi: 10.1016/j.jcv.2020.104370", "ArticleIdList": ["10.1016/j.jcv.2020.104370", "PMC7194648", "32344321"]}, {"Citation": "Schuetz P, Christ-Crain M, M\u00fcller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections\u2013hope for hype? Swiss Med Wkly. (2009) 139:318\u201326. doi: 10.4414/smw.2009.12584", "ArticleIdList": ["10.4414/smw.2009.12584", "19529989"]}, {"Citation": "Hu R, Han C, Pei S, Yin M, Chen X. Procalcitonin levels in covid-19 patients. Int J Antimicrob Agents. (2020) 56:106051. doi: 10.1016/j.ijantimicag.2020.106051", "ArticleIdList": ["10.1016/j.ijantimicag.2020.106051", "PMC7286278", "32534186"]}, {"Citation": "Yongzhi X. Covid-19-associated cytokine storm syndrome and diagnostic principles: An old and new issue. Emerg Microbes Infect (2021) 10:266\u201376. doi: 10.1080/22221751.2021.1884503", "ArticleIdList": ["10.1080/22221751.2021.1884503", "PMC7894425", "33522893"]}, {"Citation": "Hu B, Huang S, Yin L. The cytokine storm and covid-19. J Med Virol (2021) 93:250\u20136. doi: 10.1002/jmv.26232", "ArticleIdList": ["10.1002/jmv.26232", "PMC7361342", "32592501"]}, {"Citation": "Wright DJM. Prevention of the cytokine storm in covid-19. Lancet Infect Dis (2021) 21:25\u20136. doi: 10.1016/S1473-3099(20)30376-5", "ArticleIdList": ["10.1016/S1473-3099(20)30376-5", "PMC7252095", "32386610"]}, {"Citation": "Kerget B, Af\u015fin DE, Kerget F, A\u015fk\u0131n S, Akg\u00fcn M. Is metrnl an adipokine \u0130nvolved in the anti-inflammatory response to acute exacerbations of copd? Lung. (2020) 198:307\u201314. doi: 10.1007/s00408-020-00327-4", "ArticleIdList": ["10.1007/s00408-020-00327-4", "31960164"]}, {"Citation": "Rostami M, Mansouritorghabeh H. D-dimer level in covid-19 infection: A systematic review. Expert Rev Hematol (2020) 13:1265\u201375. doi: 10.1080/17474086.2020.1831383", "ArticleIdList": ["10.1080/17474086.2020.1831383", "32997543"]}, {"Citation": "Henry BM, Aggarwal G, Wong J, Benoit S, Vikse J, Plebani M, et al. . Lactate dehydrogenase levels predict coronavirus disease 2019 (covid-19) severity and mortality: A pooled analysis. Am J Emerg Med (2020) 38:1722\u20136. doi: 10.1016/j.ajem.2020.05.073", "ArticleIdList": ["10.1016/j.ajem.2020.05.073", "PMC7251362", "32738466"]}, {"Citation": "Wijarnpreecha K, Ungprasert P, Panjawatanan P, Harnois DM, Zaver HB, Ahmed A, et al. . Covid-19 and liver injury: A meta-analysis. Eur J Gastroenterol Hepatol (2021) 33:990\u20135. doi: 10.1097/MEG.0000000000001817", "ArticleIdList": ["10.1097/MEG.0000000000001817", "PMC8162043", "32639420"]}, {"Citation": "Jung TW, Pyun DH, Kim TJ, Lee HJ, Park ES, Abd El-Aty AM, et al. . Meteorin-like protein (metrnl)/il-41 improves lps-induced inflammatory responses via ampk or ppar\u03b4-mediated signaling pathways. Adv Med Sci (2021) 66:155\u201361. doi: 10.1016/j.advms.2021.01.007", "ArticleIdList": ["10.1016/j.advms.2021.01.007", "33592358"]}, {"Citation": "Gong L, Huang G, Weng L, Xu J, Li Y, Cui W, et al. . Decreased serum interleukin-41/metrnl levels in patients with graves' disease. J Clin Lab Anal (2022) 36:e24676. doi: 10.1002/jcla.24676", "ArticleIdList": ["10.1002/jcla.24676", "PMC9550969", "36036749"]}, {"Citation": "Kaiser R, Leunig A, Pekayvaz K, Popp O, Joppich M, Polewka V, et al. . Self-sustaining il-8 loops drive a prothrombotic neutrophil phenotype in severe covid-19. JCI Insight (2021) 6:e150862. doi: 10.1172/jci.insight.150862", "ArticleIdList": ["10.1172/jci.insight.150862", "PMC8492337", "34403366"]}, {"Citation": "Tobinick E, Spengler RN, Ignatowski TA, Wassel M, Laborde S. Rapid improvement in severe long covid following perispinal etanercept. Curr Med Res Opin (2022) 38:2013\u201320. doi: 10.1080/03007995.2022.2096351", "ArticleIdList": ["10.1080/03007995.2022.2096351", "35791687"]}, {"Citation": "Kalliolias GD, Ivashkiv LB. Tnf biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol (2016) 12:49\u201362. doi: 10.1038/nrrheum.2015.169", "ArticleIdList": ["10.1038/nrrheum.2015.169", "PMC4809675", "26656660"]}, {"Citation": "Jones SA, Jenkins BJ. Recent insights into targeting the il-6 cytokine family in inflammatory diseases and cancer. Nat Rev Immunol (2018) 18:773\u201389. doi: 10.1038/s41577-018-0066-7", "ArticleIdList": ["10.1038/s41577-018-0066-7", "30254251"]}, {"Citation": "Oliveira R, Cordeiro MT, Moura P, Baptista Filho PNB, Braga-Neto UM, Marques ETAJ, et al. . Serum cytokine/chemokine profiles in patients with dengue fever (df) and dengue hemorrhagic fever (fhd) by using protein array. J Clin Virol (2017) 89:39\u201345. doi: 10.1016/j.jcv.2017.02.007", "ArticleIdList": ["10.1016/j.jcv.2017.02.007", "28242509"]}, {"Citation": "Han J, Wang Y, Gan X, Song J, Sun P, Dong XP. Serum cytokine profiles of children with human enterovirus 71-associated hand, foot, and mouth disease. J Med Virol (2014) 86:1377\u201385. doi: 10.1002/jmv.23929", "ArticleIdList": ["10.1002/jmv.23929", "24619468"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "30"}, {"Year": "2023", "Month": "1", "Day": "17"}, {"Year": "2023", "Month": "2", "Day": "17", "Hour": "2", "Minute": "4"}, {"Year": "2023", "Month": "2", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "31"}], "PublicationStatus": "epublish", "ArticleIdList": ["36798115", "PMC9927217", "10.3389/fimmu.2023.1111920"]}}], "PubmedBookArticle": []}